Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 89728 · Class III · American National Red Cross (The)
Key facts
| Event ID | 89728 |
|---|---|
| Recall numbers | B-0279-2022 |
| Recalling firm | American National Red Cross (The) |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell product, for which a visual inspection was not performed or documented, was distributed. |
| Initiation date | Jan 21, 2022 |
| Report date | Mar 30, 2022 |
| Termination date | Mar 18, 2022 |
| City | Oakland |
| State | CA |
| Country | United States |
| FEI number | 2971430 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: